Press Releases

Hepion Pharmaceuticals Presents Update on CRV431 Nonclinical Studies at NASH-TAG 2020 Conference January 8, 2020
Hepion Pharmaceuticals Announces Publication in Expert Opinion on Investigational Drugs January 6, 2020
Hepion Pharmaceuticals Successfully Advances to Next Dosing Level in Ongoing Multiple Ascending Dose Clinical Study of CRV431 December 10, 2019
Hepion Pharmaceuticals to Present Clinical and Scientific Updates at HEP DART 2019 December 9, 2019
Hepion Pharmaceuticals Announces Canadian Research Team’s Academic Appointments December 3, 2019
Hepion Pharmaceuticals to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference December 3, 2019
Hepion Pharmaceuticals' CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver Disease November 20, 2019
Hepion Pharmaceuticals to Present at The Liver Meeting(R) 2019 November 7, 2019
Hepion Pharmaceuticals' CRV431 Reduces Liver Fibrosis in a Western Diet Model of NASH November 7, 2019
Hepion Pharmaceuticals to Present on CRV431 at the 3rd Annual NASH Summit October 23, 2019

Get Important News and Updates by Email Subscribe